San Diego, CA (PRWEB) July 01, 2013
AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively providing advice, taking into consideration the recent news on Actos lawsuits and potential Actos Recall lawsuit..
On June 12, a man filed a lawsuit in Louisiana Western District Court (case no. 6:2013cv01630) alleging he suffered bladder cancer from Actos. Actos is a type 2 diabetes drug, manufactured by Takeda Pharmaceutical Industries Limited and promoted a decreasing insulin resistance. In the lawsuit, the plaintiff claims that he took Actos to manage his blood sugar levels and he was diagnosed with bladder cancer after taking the drug for ten years.
Court data updated on May 14, 2013, by the US Judicial Panel on Multi-District Litigation (MDL), indicate that there are 1,548 actions pending in the Actos MDL (U.S. District Court, Western District of Louisiana, MDL 2299).
In light of the latest developments, AttorneyOne.com updated the website and, now, can actively provide advice including how to get in contact with legal counsel easily and inexpensively in case of alleged Actos severe complications. Sean Burke, director of Media Relations at AttorneyOne.com, adds "The relevant information illustrates that people continue to file Actos lawsuits". "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance."
On May 9, 2013, two men filed a lawsuit North Dakota District Court (3:2013cv00029) alleging they suffer from bladder cancer caused by Actos.
AttorneyOne.com has further information on Actos lawsuits including how to get in contact with legal counsel.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/6/prweb10880045.htm.